Exploration of the clinical application of combined endoscopic and laparoscopic surgery in early gastric cancer: 15 cases
10.3760/cma.j.cn441530-20230504-00143
- VernacularTitle:双镜联合手术在早期胃癌中的临床应用探索：15例报告
- Author:
Zhongbiao CHEN
1
;
Dazhou LI
;
Zaizhong ZHANG
;
Pan ZHAO
;
Long YI
;
Ruifeng YE
;
Qin GAO
;
Wen WANG
;
Lie WANG
Author Information
1. 福建医科大学福总临床医学院（联勤保障部队第九〇〇医院）普通外科，福州 350025
- Keywords:
Stomach neoplasms, early;
Gastroscopy;
Laparoscopy;
Laparoscopy and endoscopy cooperative surgery;
Endoscopic submucosal dissection;
Local lymph node disse
- From:
Chinese Journal of Gastrointestinal Surgery
2023;26(8):757-762
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the application of combined gastroscopy and laparoscopy (dual scope) in the treatment of early gastric cancer.Methods:In this descriptive case series study, we retrospectively collected data on 15 patients with cT1b stage gastric cancer who had undergone combined laparoscopic and endoscopic surgery in the 900th Hospital of the People's Liberation Army of China from May 2020 to October 2022. The study cohort comprised nine men and six women of median age 59 (range: 47–76) years and median body mass index 20.9 (range: 18.3–26.2) kg/m 2. Seven of the lesions were located on the lesser curvature of the gastric antrum and eight in the gastric angle. All lesions were biopsied for pathological examination and evaluated by endoscopic ultrasonography, followed by endoscopic submucosal dissection (ESD) and laparoscopic regional lymph node dissection. Studied variables included surgical and pathological features, postoperative factors, and outcomes. Results:In this group of patients, the median (range) operative time for ESD was 45 (30–82) minutes, the duration of laparoscopic lymph node dissection (45.1±8.6) minutes, and the median (range) intraoperative blood loss during lymph node dissection 30 (10–80) mL. Of the 13 patients with negative postoperative horizontal margins, four were stage SM1 and had no lymph node metastases (Stage SM1) and nine were Stage SM2, of which had one positive regional lymph node and two received additional standard distal gastrectomy with D2 lymphadenectomy concurrently because of positive ESD specimens (lymph node negative). No lymph node metastases were found in the surgical specimens of these patients. The remaining two patients had positive vertical margins; both had undergone concurrent standard distal gastrectomy with D2 lymphadenectomy. One of them was found to be lymph node positive (No. 3, one node). Four patients had impaired gastric emptying after dual-scope treatment, all of whom recovered well with symptomatic management; one patient with a suspected lymphatic leak was also managed conservatively. There were no cases of postoperative bleeding, abdominal infection, or incisional infection. At a median follow-up of 14 (6–26) months, no tumor recurrence or metastasis had been identified in any of the patients. Three patients had a grade B nutrition score 3 to 6 months after surgery, all of whom had undergone major gastrectomy, and two patients who had undergone dual-scope surgery reported an increase in acid reflux and belching after surgery compared with the preoperative period.Conclusion:A combined technique is safe and feasible for the treatment of early gastric cancer and is worthy of further exploration.
